CLK2
Basic information
Region (hg38): 1:155262868-155278491
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 34 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 1 | 1 |
Variants in CLK2
This is a list of pathogenic ClinVar variants found in the CLK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-155263271-G-A | not specified | Uncertain significance (Nov 06, 2023) | ||
1-155263972-C-T | Likely benign (Dec 31, 2019) | |||
1-155263973-G-A | not specified | Uncertain significance (May 25, 2022) | ||
1-155263981-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
1-155264003-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
1-155264014-C-A | not specified | Uncertain significance (Dec 01, 2022) | ||
1-155264239-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
1-155264254-C-G | not specified | Uncertain significance (Mar 24, 2023) | ||
1-155264262-C-G | not specified | Uncertain significance (Mar 29, 2023) | ||
1-155265882-T-C | not specified | Uncertain significance (Sep 28, 2022) | ||
1-155266762-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
1-155266765-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
1-155268012-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
1-155268031-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
1-155268052-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
1-155268064-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
1-155268115-C-T | not specified | Uncertain significance (May 23, 2023) | ||
1-155269511-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
1-155269517-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
1-155269528-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
1-155269553-G-A | not specified | Uncertain significance (May 30, 2023) | ||
1-155269565-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
1-155269579-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-155269646-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
1-155269652-G-A | not specified | Uncertain significance (Jul 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLK2 | protein_coding | protein_coding | ENST00000361168 | 12 | 15624 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000277 | 125745 | 0 | 3 | 125748 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.20 | 226 | 340 | 0.665 | 0.0000244 | 3270 |
Missense in Polyphen | 75 | 143.15 | 0.52394 | 1490 | ||
Synonymous | 0.244 | 109 | 112 | 0.971 | 0.00000617 | 941 |
Loss of Function | 5.45 | 2 | 38.4 | 0.0520 | 0.00000295 | 328 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. {ECO:0000269|PubMed:10480872, ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:8910305, ECO:0000269|PubMed:9637771}.;
- Pathway
- mRNA Processing
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.0785
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.73
Haploinsufficiency Scores
- pHI
- 0.350
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clk2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- protein phosphorylation;response to ionizing radiation;peptidyl-tyrosine phosphorylation;response to retinoic acid;regulation of RNA splicing;negative regulation of gluconeogenesis;protein autophosphorylation
- Cellular component
- nucleus;nucleoplasm;nuclear body;nuclear speck
- Molecular function
- protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;identical protein binding